User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Journal article
    Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: Results of the GRAAL1
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K Herbrecht, R. (2003) Journal of Clinical Oncology — Vol. 21, no. 23, p. 4402-4406 (2003)
    • Journal article
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Speech
    Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).
    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Herbrecht, R. Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K (2002) 44th Annual Meeting of the American-Society-of-Hematology — PHILADELPHIA(Pennsylvania)
    • Journal article
    Sequential Induction Chemotherapy With Vincristine, Daunorubicin, Cyclophosphamide, and Prednisone in Adult Acute Lymphoblastic-leukemia
    Thomas, X. Danaila, C. Bach, QK. Dufour, Philippe[UCL] Christian, B. Corront, B. Bosly, André[UCL] Bastion, Y. Gratecos, N. Leblay, R. Sebban, C. Archimbaud, E. Fiere, D. (1995) Annals of Hematology — Vol. 70, no. 2, p. 65-69 (1995)
    • Journal article
    Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'adulte
    Feugier, P Van Hoof, A. Sebban, C. Solal-Celigny, P. Bouabdallah, R. Ferme, C Christian, B. Lepage, E. Tilly, H. Morschhauser, F. Gaulard, P. Salles, G. Bosly, André[UCL] Gisselbrecht, C. Reyes, F. Coiffier, B. (2005) Journal of Clinical Oncology — Vol. 23, no. 18, p. 4117-4126 (2005)
    • Journal article
    Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1b)
    Ketterer, N. Coiffier, B. Thieblemont, C. Fermé, C. Brière, J. Casasnovas, O. Bologna, S. Christian, B. Connerotte, Thierry[UCL] Réher, C. Bordessoule, D. Fruchart, C. Delarue, R. Bonnet, C. Morschhauser, F. Anglaret, B. Soussain, C. Fabiani, B. Tilly, H. Haioun, C. (2013) Annals of Oncology — Vol. 24, no. 4, p. 1032-1037 (2013)